You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 2, FEBRUARY 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Treatment of Moderate and Severe Pneumococcal Pneumonia with Oral Phenoxymethyl Penicillin

JOHN T. REEVES, M.D.; JAMES GARFIELD, M.D.; NATHAN POLASKY, M.D.; MORTON HAMBURGER, M.D.

AMA Arch Intern Med. 1959;103(2):184-188.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The successful treatment of pneumococcal pneumonia with oral phenoxymethyl penicillin (penicillin V) has been reported by several investigators.1-3 Because encouraging results of therapy observed during a single season are often not confirmed by study over a longer period of time it is always reassuring to report the repetition of therapeutic trials which at first show promise. The present report, therefore, adds our experience of 1956-1957 to that of 1955-1956, which was the basis of our first communication on this subject.1 The second year, in general, confirmed the initial experience.

Plan of Study

The plan of study was similar to that of the first year of the program. All patients with pneumonia admitted to the Cincinnati General Hospital were screened by one of us and included in the study with the following exceptions: (1) those suspected of having nonpneumococcal pneumonia; (2) those unable to take oral medication, usually because . . . [Full Text PDF of this Article]


Author Affiliations

Cincinnati

From the Infectious Disease Laboratory, Department of Medicine, University of Cincinnati College of Medicine and the Cincinnati General Hospital.


Footnotes

Submitted for publication June 16, 1958.

This investigation was supported by a grant-in-aid from Wyeth Laboratories, Inc. The pencillin V was supplied by the Wyeth Laboratories, Inc. through the courtesy of Dr. Edward F. Roberts.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.